ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 85 filers reported holding ADAMAS PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $1,366,000 | -75.1% | 159,924 | -41.5% | 0.16% | -71.6% |
Q3 2018 | $5,477,000 | -35.4% | 273,593 | -16.6% | 0.55% | -36.8% |
Q2 2018 | $8,477,000 | +69.2% | 328,193 | +56.5% | 0.87% | +40.5% |
Q1 2018 | $5,010,000 | -78.7% | 209,644 | -69.7% | 0.62% | -80.5% |
Q4 2017 | $23,483,000 | +21.2% | 692,913 | -24.3% | 3.17% | +28.3% |
Q3 2017 | $19,371,000 | +200.8% | 915,000 | +148.5% | 2.47% | +167.4% |
Q2 2017 | $6,439,000 | +137.3% | 368,166 | +137.5% | 0.92% | +115.1% |
Q1 2017 | $2,713,000 | +23.5% | 155,000 | +19.2% | 0.43% | +2.1% |
Q4 2016 | $2,197,000 | -99.9% | 130,000 | 0.0% | 0.42% | +24.2% |
Q3 2016 | $2,133,300,000 | +108299.4% | 130,000 | 0.0% | 0.34% | -2.9% |
Q2 2016 | $1,968,000 | – | 130,000 | – | 0.35% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
C Partners Holding GmbH | 1,474,482 | $38,661,000 | 18.12% |
GREAT POINT PARTNERS LLC | 772,600 | $20,258,000 | 7.90% |
BOW STREET LLC | 126,870 | $3,327,000 | 1.61% |
Opaleye Management Inc. | 150,000 | $3,933,000 | 1.56% |
EMERALD MUTUAL FUND ADVISERS TRUST | 316,690 | $8,304,000 | 0.64% |
WALL STREET ASSOCIATES | 225,000 | $5,899,000 | 0.56% |
Granite Point Capital Management, L.P. | 61,813 | $1,621,000 | 0.47% |
EMERALD ADVISERS, LLC | 348,721 | $9,143,000 | 0.44% |
TFS CAPITAL LLC | 97,652 | $2,560,000 | 0.25% |
Spark Investment Management LLC | 59,300 | $1,553,000 | 0.22% |